Megan E. Dellinger
View All Practices
Megan’s practice focuses on patent infringement litigation.
She represents clients in a variety of technological fields, particularly in the pharmaceutical and chemical arts. Her experience also includes inter partes review (IPR) proceedings. Megan has been involved in all phases of litigation, including motions practice, discovery, trial, and appeal.
Prior to attending law school, Megan worked as a research and development chemist for a specialty chemical manufacturer, developing new synthetic products and optimizing existing manufacturing processes.
Megan has been included in Best Lawyers: Ones to Watch for her patent and intellectual property work.
Experience
Represented Recro Gainesville LLC as a member of a lead counsel team in patent infringement cases in the District of Delaware involving Zohydro® ER, an extended release hydrocodone formulation. Recro Gainesville LLC v. Actavis Laboratories FL, Inc., C.A. No. 14-1118-GMS (D. Del.) and Recro Gainesville LLC v. Alvogen Malta Operations Ltd., C.A. No. 14-1364-GMS (D. Del.)
Represented Recro Gainesville LLC in defendant’s appeal of Recro Gainesville LLC v. Actavis Laboratories FL, Inc., C.A. No. 14-1118-GMS (D. Del.). Recro Gainesville LLC v. Actavis Labs. FL, Inc., No. 2017-1822 (Fed. Cir.)
Represented medical device manufacturer Edwards Lifesciences Corporation in patent infringement action in the District of Delaware. Boston Sci. Corp. v. Edwards Lifesciences Corp., C.A. No. 16-275-SLR (D. Del.)
Represented Edwards Lifesciences Corporation in related IPR proceedings concerning transcatheter heart valve technology. Edwards Lifesciences Corp. v. Boston Scientific Scimed, Inc., IPR2017-00060
Represented Next Caller, a subsidiary of Pindrop, at trial in a patent infringement action relating to call authentication solutions used by call centers. TRUSTID, Inc. v. Next Caller Inc., C.A. No. 18-172-MN (D. Del.)
Member of a team that served as co-lead counsel for plaintiffs in Abbreviated New Drug Application (ANDA) patent infringement cases in the District of Delaware involving UCB’s Vimpat® drug for the treatment of epilepsy. UCB, Inc. et al. v. Accord Healthcare, Inc. et al., C.A. No. 13-1206-LPS (D. Del.)
Represented Agilent Technologies and Aurora SFC Systems, Inc. as a member of a lead counsel team in patent infringement action on liquid chromatography systems. Waters Techs. Corp. v. Aurora SFC Sys. Inc., C.A. No. 11-708-RGA (D. Del.)
Worked on behalf of defendants Sprint and Simplexity as lead counsel and also represented HTC in patent infringement case in the District of Delaware. EON Corp. IP Holdings LLC v. FLO TV Inc., et al., C.A. No. 10-812-RGA (D. Del.)
Represented Sprint in plaintiff’s appeal of EON Corp. IP Holdings LLC v. FLO TV Inc., et al., C.A. No. 10-812-RGA (D. Del.). EON Corp. IP Holdings LLC v. AT&T Mobility LLC, No. 2014-1392 (Fed. Cir.)
Member of lead counsel team representing Sprint in multi-defendant patent litigation in the District of Delaware. CallWave Communications, LLC v. Sprint Nextel Corp. & Google, C.A. No. 12-1702-RGA (D. Del.)
Represented Rite Aid as a member of a lead counsel team and also represented CVS in patent infringement case involving refill-by-scan mobile applications for use with iPhones and Android devices. Walgreen Co. v. Rite Aid Corp., C.A. No. 14-124-GMS (D. Del.)
News & Insights
Client Alert, 02.14.2023A look back at patent filings, trials, decisions on key issues, and notable developments in the US District Court for the District of Delaware in 2022.
Professional & Civic
American Bar Association
Delaware State Bar Association
Federal Bar Association
Education
University of Virginia School of Law, JD, order of the coif, 2012
Virginia Law Review, executive editor, 2011-2012; editorial board member, 2010-2011
College of William & Mary, BS, Chemistry, summa cum laude, Phi Beta Kappa, 2005
Admissions
- Delaware, 2012
- US District Court for the District of Delaware, 2013
- US Court of Appeals for the Federal Circuit, 2014